Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells

Stem Cell Research and Therapy

Volumn 4, Issue 6, 2013, Pages

  Misuno, Kaori ^a,b   Liu, Xiaojun ^a,b   Feng, Sizhe ^a,b   Hu, Shen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER STEM CELL; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; SPHEROID CELL; TANDEM MASS SPECTROMETRY; UPREGULATION;

CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; PHOSPHOGLYCERATE KINASE; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84890836195     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt386     Document Type: Article

References (60)

1. Cancer statistics, 2011. Siegel R, Ward E, Brawley O, Jemal A, CA Cancer J Clin 2011 61 212 236 10.3322/caac.20121 21685461
2. Second primary tumors in patients with oral cancer. Day GL, Blot WJ, Cancer 1992 70 14 19 10.1002/1097-0142(19920701)70:1<14::AID- CNCR2820700103>3.0.CO;2-S 1606536
3. Molecular markers of the risk of oral cancer. Lippman SM, Hong WK, N Eng J Med 2001 344 1323 1326 10.1056/NEJM200104263441710 (Pubitemid 32372968)
4. Molecular changes in the multistage pathogenesis of head and neck cancer. Park BJ, Chiosea SI, Grandis JR, Cancer Biomark 2011 9 325 339
5. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM, Cancer Res 2006 66 9339 9344 10.1158/0008-5472.CAN-06-3126 16990346 (Pubitemid 44623625)
6. Cancer stem cells: models and concepts. Dalerba P, Cho RW, Clarke MF, Annu Rev Med 2007 58 267 284 10.1146/annurev.med.58.062105.204854 17002552 (Pubitemid 46706514)
7. Cancer stem cells. Jordan CT, Guzman ML, Noble M, N Eng J Med 2006 355 1253 1261 10.1056/NEJMra061808 (Pubitemid 44427449)
8. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Visvader JE, Lindeman GJ, Nat Rev Cancer 2008 8 755 768 10.1038/nrc2499 18784658
9. Identification of human brain tumour initiating cells. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB, Nature 2004 432 396 401 10.1038/nature03128 15549107 (Pubitemid 39551674)
10. Identification and expansion of human colon-cancer-initiating cells. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R, Nature 2007 445 111 115 10.1038/nature05384 17122771 (Pubitemid 46067311)
11. Molecular definition of breast tumor heterogeneity. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K, Cancer Cell 2007 11 259 273 10.1016/j.ccr.2007.01.013 17349583 (Pubitemid 46349843)
12. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME, Head Neck 2010 32 1195 1201 10.1002/hed.21315 20073073
13. A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD, Cancer Lett 2010 289 151 160 10.1016/j.canlet. 2009.08.010 19748175
14. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W, Cancer Lett 2009 277 227 234 10.1016/j.canlet.2008.12.015 19185988
15. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE, Proc Natl Acad Sci U S A 2007 104 973 978 10.1073/pnas.0610117104 17210912 (Pubitemid 46154721)
16. Cancer stem cells in head and neck squamous cell cancer. Prince ME, Ailles LE, J Clin Oncol 2008 26 2871 2875 10.1200/JCO.2007.15.1613 18539966
17. Positive correlations of Oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF, Clin Cancer Res 2008 14 4085 4095 10.1158/1078-0432.CCR-07-4404 18593985
18. Transcriptional regulation by the phosphorylation-dependent factor CREB. Mayr B, Montminy M, Nat Rev Mol Cell Biol 2001 2 599 609 10.1038/35085068 11483993 (Pubitemid 33674011)
19. CREB-a real culprit in oncogenesis. Siu YT, Jin DY, FEBS J 2007 274 3224 3232 10.1111/j.1742-4658.2007.05884.x 17565603 (Pubitemid 47024982)
20. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Sakamoto KM, Frank DA, Clin Cancer Res 2009 15 2583 2587 10.1158/1078-0432.CCR-08-1137 19351775
21. iTRAQ-based shotgun neuroproteomics. Liu T, Hu J, Li H, Methods in Molecular Biology. volume 566 Clifton, NJ, USA: Humana Press 2009 201 216
22. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Dayon L, Hainard A, Licker V, Turck N, Kuhn K, Hochstrasser DF, Burkhard PR, Sanchez JC, Anal Chem 2008 80 2921 2931 10.1021/ac702422x 18312001 (Pubitemid 351556457)
23. Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ, Mol Cell Proteomics 2004 3 1154 1169 10.1074/mcp.M400129-MCP200 15385600
24. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Huang DW, Sherman BT, Lempicki RA, Nat Protocols 2008 4 44 57 10.1038/nprot.2008.211
25. Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma. Nakayama S, Sasaki A, Mese H, Alcalde RE, Matsumura T, Invasion Metastasis 1998 18 219 228 10.1159/000024515 10729767 (Pubitemid 30223698)
26. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA, Cancer Cell 2006 9 391 403 10.1016/j.ccr.2006.03.030 16697959 (Pubitemid 43668737)
27. High-efficiency RNA interference in human embryonic stem cells. Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, Daley GQ, Stem Cells 2005 23 299 305 10.1634/stemcells.2004-0252 15749924 (Pubitemid 40404448)
28. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL, Cancer Res 2008 68 6281 6291 10.1158/0008-5472.CAN-08-0094 18676852
29. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Niwa H, Ogawa K, Shimosato D, Adachi K, Nature 2009 460 118 122 10.1038/nature08113 19571885
30. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E, du Manoir S, PLoS One 2010 5 8960 10.1371/journal.pone.0008960 20126410
31. Oncogenicity of the developmental transcription factor sox9. Matheu A, Collado M, Wise C, Manterola L, Cekaite L, Tye AJ, Canamero M, Bujanda L, Schedl A, Cheah KS, Skotheim RI, Lothe RA, López-de-Munain A, Briscoe J, Serrano M, Lovell-Badge R, Cancer Res 2012 72 1301 1315 10.1158/0008-5472.CAN- 11-3660 22246670
32. The role of hypoxia-induced factors in tumor progression. Vaupel P, Oncologist 2004 9 10 17 (Pubitemid 39658341)
33. Expression of PGK1 by prostate cancer cells induces bone formation. Jung Y, Shiozawa Y, Wang J, Wang J, Wang Z, Pedersen EA, Lee CH, Hall CL, Hogg PJ, Krebsbach PH, Keller ET, Taichman RS, Mol Cancer Res 2009 7 1595 1604 10.1158/1541-7786.MCR-09-0072 19825988
34. Induction of tumor stem cell differentiation-novel strategy to overcome therapy resistance in gastric cancer. Zieker D, Bühler S, Ustündag Z, Königsrainer I, Manncke S, Bajaeifer K, Vollmer J, Fend F, Northoff H, Königsrainer A, Glatzle J, Langenbecks Arch Surg 2013 398 603 608 10.1007/s00423-013-1058-5 23412594
35. The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells. Baris OR, Klose A, Kloepper JE, Weiland D, Neuhaus JF, Schauen M, Wille A, Müller A, Merkwirth C, Langer T, Larsson NG, Krieg T, Tobin DJ, Paus R, Wiesner RJ, Stem Cells 2011 29 1459 1468 21780252
36. Lamin A: a putative colonic epithelial stem cell biomarker which identifies colorectal tumours with a more aggressive phenotype. Willis N, Wilson R, Hutchison C, Biochem Soc Trans 2008 36 1350 1353 10.1042/BST0361350 19021554
37. Lamin A/C is a risk biomarker in colorectal cancer. Willis ND, Cox TR, Rahman-Casañs SF, Smits K, Przyborski SA, van den Brandt P, van Engeland M, Weijenberg M, Wilson RG, de Bruïne A, Hutchison CJ, PLoS One 2008 3 2988 10.1371/journal.pone.0002988 18714339
38. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG, Carcinogenesis 2004 25 1157 1163 10.1093/carcin/bgh113 14963017 (Pubitemid 38968043)
39. The bioenergetic signature of cancer: a marker of tumor progression. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC, Cancer Res 2002 62 6674 6681 12438266 (Pubitemid 35364137)
40. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, Reed JC, Cuezva JM, Biochem J 2004 378 17 20 10.1042/BJ20031541 14683524 (Pubitemid 38299539)
41. Gs signaling in osteoblasts and hematopoietic stem cells. Kronenberg HM, Ann N Y Acad Sci 2010 1192 327 329 10.1111/j.1749-6632.2009.05251.x 20392255
42. G protein coupled receptors in embryonic stem cells: a role for Gs-alpha signaling. Layden BT, Newman M, Chen F, Fisher A, Lowe WL Jr, PLoS One 2010 5 9105 10.1371/journal.pone.0009105 20161705
43. G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. Nakamura K, Salomonis N, Tomoda K, Yamanaka S, Conklin BR, PLoS One 2009 4 7780 10.1371/journal.pone.0007780 19936228
44. Regulation of stem cell pluripotency and differentiation by G protein coupled receptors. Callihan P, Mumaw J, Machacek DW, Stice SL, Hooks SB, Pharmacol Ther 2011 129 290 306 10.1016/j.pharmthera.2010.10.007 21073897
45. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Gemei M, Mirabelli P, Di Noto R, Corbo C, Iaccarino A, Zamboli A, Troncone G, Galizia G, Lieto E, Del Vecchio L, Salvatore F, Cancer 2013 119 729 738 10.1002/cncr.27794 23027178
46. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. Strickland LA, Ross J, Williams S, Ross S, Romero M, Spencer S, Erickson R, Sutcliffe J, Verbeke C, Polakis P, van Bruggen N, Koeppen H, J Pathol 2009 218 380 390 10.1002/path.2545 19334050
47. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ, Oncogene 2007 26 467 476 10.1038/sj.onc.1209802 16878157 (Pubitemid 46122837)
48. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Ferris RL, Xi L, Seethala RR, Chan J, Desai S, Hoch B, Gooding W, Godfrey TE, Clin Cancer Res 2011 17 1858 1866 10.1158/1078-0432.CCR-10-3110 21355082
49. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy. Ferris RL, Stefanika P, Xi L, Gooding W, Seethala RR, Godfrey TE, Laryngoscope 2012 122 1020 1030 10.1002/lary.22467 22447185
50. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, Godfrey TE, Cancer Res 2005 65 2147 2156 10.1158/0008-5472.CAN-04-3717 15781625 (Pubitemid 40490121)
51. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Scheel C, Weinberg RA, Sem Cancer Biol 2012 22 396 403 10.1016/j.semcancer.2012.04.001
52. The epithelial-mesenchymal transition generates cells with properties of stem cells. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA, Cell 2008 133 704 715 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
53. Generation of breast cancer stem cells through epithelial-mesenchymal transition. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A, PLoS One 2008 3 2888 10.1371/journal.pone.0002888 18682804
54. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Xing J, Ginty D, Greenberg M, Science 1996 273 959 963 10.1126/science.273.5277.959 8688081 (Pubitemid 26275173)
55. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Yamamoto KK, Gonzalez GA, Biggs WH, Montminy MR, Nature 1988 334 494 498 10.1038/334494a0 2900470
56. CREB is a regulatory target for the protein kinase Akt/PKB. Du K, Montminy M, J Biol Chem 1998 273 32377 32379 10.1074/jbc.273.49.32377 9829964 (Pubitemid 28557606)
57. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. Deak M, Clifton AD, Lucocq LM, Alessi DR, EMBO J 1998 17 4426 4441 10.1093/emboj/17.15. 4426 9687510 (Pubitemid 28362632)
58. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. Tan Y, EMBO J 1996 15 4629 4642 8887554 (Pubitemid 26294581)
59. Calcium calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Matthews R, Mol Cell Biol 1994 14 6107 6116 10.1128/MCB.14.9.6107 8065343 (Pubitemid 24264440)
60. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Cheng JC, Kinjo K, Judelson DR, Chang J, Wu WS, Schmid I, Shankar DB, Kasahara N, Stripecke R, Bhatia R, Landaw EM, Sakamoto KM, Blood 2008 111 1182 1192 17975014 (Pubitemid 351213399)